2nd Quarter - Amendment

GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Firm
Client
Income
—
Expenses
$260,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 21, 2008 $250,000 Replaced
2nd Quarter - Amendment (this page) Oct 28, 2008 $260,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

International Trade Issues Global Health Issues Domestic HIV Policy Issues H.R.5501, S.2731 - Lantos and Hyde US Global Leadership Against HIV AIDS H.R. 1943 - Stop AIDS in Prison Act H.R. 822 - Routine HIV/AIDS Screening Coverage Act S. 2162 - Veterans' Mental Health and other Care Improvements Act H.R. 6114 - Simplifying and Updating National Standards to Encourage Testing of the Human Immunodeficiency Virus Act

LobbyistCovered position, as disclosed
CRISTIN LIS —

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 2162 (110th), H.R. 822 (110th), H.R. 5501 (110th), S. 2731 (110th), H.R. 1943 (110th), H.R. 6114 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.